MusclePharm(R) Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, reported Bodybuilding.com selected MusclePharm as the Supplement Company of the Month for October.
New Dragon Asia Corporation (AMEX: NWD), one of China's leading producers of instant noodles, flour-related products and soybean derived products, recently announced that on October 5, 2010 it received a letter from NYSE Amex LLC indicating that it failed to satisfy certain of AMEX's continued listing standards.
Rexahn Pharmaceuticals, Inc. (AMEX: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, recently announced the publication of a research article in Drug Development Research on the neuroprotective effects of clavulanic acid, the active pharmaceutical ingredient of Serdaxin®, Rexahn’s lead CNS therapeutic currently in Phase II clinical trials.
Uranium Energy Corp (AMEX: UEC) recently announced that the Company has now completed the first of three phases of wellfield development at Production Area One at the Palangana ISR uranium project located in South Texas.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).